TP53 and B-cell chronic lymphocytic leukemia: In addition, in sensitive samples (as we previously reported in p53 deficient CLL lymphocytes) Dasatinib failed to induce AMPK phosphorylation or autophagy at lower nM concentrations (IC50s) or clinical achievable concentrations (180nM) (data not shown).